Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Lymphoma, Large B-Cell, Diffuse 12Burkitt Lymphoma 8Lymphoma, Follicular 7Sarcoma 5Lymphoma, Non-Hodgkin 5Hodgkin Disease 5Neoplasms 4Lymphoma 4Wilms Tumor 3Sarcoma, Ewing 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Osteosarcoma 3Lymphoma, B-Cell 3Liposarcoma 3Endometrial Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Plasmablastic Lymphoma 2Ovarian Neoplasms 2Multiple Myeloma 2Lymphoproliferative Disorders 2Lymphoma, T-Cell 2Lymphoma, Mantle-Cell 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Ganglioneuroblastoma 2Fallopian Tube Neoplasms 2Down Syndrome 2Dermatofibrosarcoma 2

Interventions

Cyclophosphamide 23fludarabine 15fludarabine phosphate 10Methotrexate 10blinatumomab 9Whole-Body Irradiation 9Vincristine 7Specimen Handling 7Dexamethasone 7merphos 6Tacrolimus 6Mycophenolic Acid 6Stem Cell Transplantation 5Peripheral Blood Stem Cell Transplantation 5Mesna 5Mercaptopurine 5Melphalan 5Leukapheresis 5Granulocyte Colony-Stimulating Factor 5Filgrastim 5Cytarabine 5Cyclosporine 5Biopsy 5pegaspargase 4Prednisone 4Magnetic Resonance Spectroscopy 4Etoposide 4Calcium Dobesilate 4Busulfan 4prednylidene 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × Doxorubicin × 30 days × Clear all
NCT00792948 2026-05-29

Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia

National Cancer Institute (NCI)

Phase 2 Active not recruiting
97 enrolled 7 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT01190930 2026-05-28

Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma

Children's Oncology Group

Phase 3 Completed
9,350 enrolled 51 charts
LymphoidOther hematologic neoplasm

Down Syndrome, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡